Endonovo Therapeutics Engages ShareIntel, A Leader In Shareholder Intelligence Services To Investigate Market Maker and Clearing Firm Irregularities
11 janv. 2018 09h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a clinical-stage developer of non-invasive electroceuticals for the...